Almeda Ventures Limited Partnership (TLV:AMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA 266.60
-8.00 (-2.91%)
At close: Sep 1, 2026
TLV:AMDA Market Cap
TLV:AMDA has a market cap or net worth of 52.08 million as of September 2, 2026. Its market cap has increased by 84.41% in one year.
Market Cap
52.08M
Enterprise Value
12.38M
Revenue
31.99M
Ranking
n/a
PE Ratio
1.69
Stock Price
266.60
ChartMarket Cap Chart
Since October 7, 2020, TLV:AMDA's market cap has decreased from 53.94M to 52.08M, a decrease of -3.46%. That is a compound annual growth rate of -0.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 51.71M | 42.80% |
| Dec 30, 2025 | 36.21M | 39.40% |
| Dec 25, 2024 | 25.98M | 2.44% |
| Dec 31, 2023 | 25.36M | 55.32% |
| Dec 29, 2022 | 16.33M | -70.81% |
| Dec 30, 2021 | 55.94M | 14.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 127.48B |
| Danel (Adir Yeoshua) | 2.58B |
| Amal Holdings A.D. | 2.25B |
| BrainsWay | 1.73B |
| Nissan Medical Industries | 81.69M |
| Matricelf | 80.34M |
| Epitomee Medical | 68.12M |
| Clal Biotechnology Industries | 36.86M |